RE:So Canada is saying best case $15 -30 but I did not say best case was $15-$30. I said most likely take out price around that range.
Best case?
they get to phase 3 with a partner, that does not completely take out.
then able to continue getting to market & do so.
As well as continuing to co- market with other branches of cancer.
That would be the best possible outcome for Onc.
share price?
Pick a number....
way too many variables to speculate.
The short term take out number is based on a the comparable on onc web site, of recent take over deals.
That being virolyitics at about $500 milll, & others closer to one billion.
Hence the $15-$30 price.
The maximum outcome number, would be 1-3 years away, with so many unpredictable major & minor changes....too hard to pick any number that could be justified, with any argument.
Unpredictable? Six months ago, the world was floating on one of the best economic runs in history.
Then along came Covid.
ONC could come up with multiple side deals, similar to Bracelet, for each sub cancer type.
Some totally random, craziness could happen within Onc mangement; They could try to take private & move away from the day traders & shorting.
My point is, to get to the maximum possible best outcome for Onc, many things have to go right & over a period of 1-3 years.
My prediction?
Over the next 3 years for Onc.
some things will go great, some not so good & some terrible.
And..just like Covid, oil prices below zero, global warming, Some things will happen totally unimaginable.
Not a slam against Onc virus or mangement, just reality.
ONC recent announcements from trials, abstracts, studies; have all been good to great.
Everyone needs to realize to get a drug to market is a very long walk. Sometimes many steps forward & sometimes a few back.
in it's presentation, mangement talks about the biomarkers etc.
The DNA diagnostics technology they are using to identify the 2 biomarkers they now have clearly proven, barely existed 2 years ago.
Two years from now?
ONC could become a marketable cancer VACCINE! ...for various strains.
pick a share price.....
Why has big pharm not stepped up yet? They have, just not all- in , until a market potential can be proven.
For their drugs alongside palareorep.....